Filters close

Showing results

110 of 7793
Released: 27-Jun-2022 4:05 PM EDT
Study finds COVID-19 omicron variant leads to less severe disease in mice
Georgia State University

Georgia State University researchers have found that the Alpha, Beta and Delta variants of SARS-CoV-2 were substantially more fatal in mouse models than the original strain of the virus that causes COVID-19.

Released: 27-Jun-2022 3:55 PM EDT
Structural Racism Drives Higher COVID-19 Death Rates in Louisiana, Study Finds
University of Maryland, College Park

Disproportionately high COVID-19 mortality rates among Black populations in Louisiana parishes are the result of longstanding health vulnerabilities associated with institutional and societal discrimination, according to research conducted by an interdisciplinary team under the mentorship of University of Maryland (UMD) Clark Distinguished Chair Deb Niemeier and UMD Associate Professor of Kinesiology Jennifer D. Roberts in the School of Public Health.

Released: 27-Jun-2022 3:50 PM EDT
Canada's COVID-19 Response in First 2 Years of Pandemic Compares Well with Other Countries' Measures
Canadian Medical Association Journal

Compared with other G10 countries, Canada handled the first 2 years of the COVID-19 pandemic well by most measures, according to an analysis in CMAJ (Canadian Medical Association Journal).

Released: 27-Jun-2022 3:05 PM EDT
Kids and the COVID-19 Vaccine: Eleven Key Questions Answered
Children's Hospital Los Angeles

With the vaccine for children ages 6 months and older approved, the experts at Children’s Hospital Los Angeles provide guidance for families. The Centers for Disease Control and Prevention (CDC) recommends that everyone approved to receive a COVID-19 vaccine get one—including children ages 6 months and older.

Newswise: The Surprising Link Between SARS-COV-2 Infection and New-Onset Diabetes
Released: 27-Jun-2022 1:45 PM EDT
The Surprising Link Between SARS-COV-2 Infection and New-Onset Diabetes
Osaka University

Researchers from Osaka University find that infection with SARS-CoV-2 activates the IRF1 gene and impairs insulin/IGF signaling in the lung, liver, adipose tissue, and pancreatic cells

Released: 27-Jun-2022 1:05 PM EDT
Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds
Mayo Clinic

A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to Mayo Clinic researchers.

Newswise: Rensselaer Researchers Receive $3.5 Million Grant for Development of COVID Antiviral Drug
Released: 27-Jun-2022 10:05 AM EDT
Rensselaer Researchers Receive $3.5 Million Grant for Development of COVID Antiviral Drug
Rensselaer Polytechnic Institute (RPI)

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop a low-dose, oral COVID antiviral drug that can be administered at home.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2022 8:00 AM EDT Released to reporters: 24-Jun-2022 12:45 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2022 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Jun-2022 11:05 AM EDT
COVID-19 Vaccination in Pregnancy Helps Protect Infants from Needing Hospital Care for COVID-19
Ann and Robert H. Lurie Children's Hospital of Chicago

In a new study sponsored by the Centers for Disease Control and Prevention and published in the New England Journal of Medicine, researchers provide additional evidence that COVID-19 vaccination during pregnancy helps protect babies younger than 6 months from being hospitalized due to COVID-19. The risk of COVID-19 hospitalization among babies was reduced by about 80 percent during the Delta wave (July 1–December 18, 2021) and 40 percent during the Omicron wave (December 19–March 8, 2022).

Released: 23-Jun-2022 5:05 PM EDT
Methods from weather forecasting can be adapted to assess risk of COVID-19 exposure
California Institute of Technology

Techniques used in weather forecasting can be repurposed to provide individuals with a personalized assessment of their risk of exposure to COVID-19 or other viruses, according to new research published by Caltech scientists.

Showing results

110 of 7793